28.23USD-3.98%Mkt Cap: 1.67B USDP/E: —Last update: 2026-06-01
Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-ty…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.67B USD
Enterprise Value1.11B USD
Revenue (TTM)66.05M USD
Gross Profit47.68M USD
Net Income (TTM)-412.78M USD
Revenue/Share1.133 USD
Last Price28.23 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees539
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS00847X1046
Valuation
P/E (Trailing)—
P/E (Forward)-6.39
PEG—
EV/EBITDA-2.36
EV/Revenue16.77
P/S26.47
P/B1.57
EPS (TTM)-7.26
EPS (Forward)-4.60
52W Range
22.2425% of range46.00
52W High46.00 USD
52W Low22.24 USD
Profitability
Gross Margin88.26%
Oper. Margin-530.34%
EBITDA Margin0.00%
Profit Margin-764.01%
ROE-34.60%
ROA-31.82%
Growth
Revenue Growth137.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-372.98M USD
CapEx (TTM)14.32M USD
FCF Margin-404.59%
FCF Yield-15.96%
Net Debt-701.29M USD
Net Debt/EBITDA1.49
Balance Sheet
Debt/Equity0.03
Current Ratio14.19
Quick Ratio12.80
Book Value/Sh18.69 USD
Cash/Share12.39 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)41.13 USD
Target Range28.00 USD – 60.00 USD
# Analysts8
Ownership
Shares Out.59.47M
Float53.13M
Insiders1.09%
Institutions108.65%
Short Interest
Short Ratio6.0d
Short % Float12.66%
Short % Out.12.53%
Shares Short7.45M
Short (prev mo.)7.08M
Technical
SMA 5029.50 (-4.3%)
SMA 20032.34 (-12.7%)
Beta0.58
S&P 52W Chg27.94%
Avg Vol (30d)1.09M
Avg Vol (10d)758.33K
Technical Indicators
RSI (14)54.2
MACD0.0785
MACD Signal-0.1982
MACD Hist.+0.2767
BB Upper29.83 USD
BB Middle28.27 USD
BB Lower26.71 USD
BB Width11.05%
ATR (14)1.261 USD
Vol Ratio (20d)1.04x